DENVER, Feb. 14, 2024 /PRNewswire/ — Antero Midstream Corporation (NYSE: AM) (“Antero Midstream” or the “Company”) today announced its fourth quarter 2023 financial and operating results and 2024 guidance. In addition, Antero Midstream announced the authorization of a $500 million share repurchase program. The relevant consolidated financial statements are included in Antero Midstream’s Annual Report on… Continue reading Antero Midstream Announces Fourth Quarter 2023 Results, 2024 Guidance and $500 Million Share Repurchase Program
Category: Newswire
ACRES Commercial Realty Corp. to Report Results for Fourth Quarter and Year Ended December 31, 2023
UNIONDALE, N.Y., Feb. 14, 2024 /PRNewswire/ — ACRES Commercial Realty Corp. (NYSE:ACR) (the “Company”) announced today that it will release its results for the fourth quarter and year ended December 31, 2023, on Wednesday, February 28, 2024, after the market closes. The Company invites investors and other interested parties to listen to its live conference… Continue reading ACRES Commercial Realty Corp. to Report Results for Fourth Quarter and Year Ended December 31, 2023
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO, Feb. 14, 2024 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2023 and provided an update on… Continue reading Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
Realty Income Announces Appointment of Jeff A. Jacobson to Board of Directors and Retirement of Board Member Ronald L. Merriman
SAN DIEGO, Feb. 14, 2024 /PRNewswire/ — Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company®, today announced that Jeff A. Jacobson will be joining Realty Income’s Board of Directors (the “Board”), effective February 21, 2024. Ronald L. Merriman has also announced his intention to retire from the Board and to not stand for… Continue reading Realty Income Announces Appointment of Jeff A. Jacobson to Board of Directors and Retirement of Board Member Ronald L. Merriman
SightGlass Vision Receives Breakthrough Device Designation from U.S. Food and Drug Administration
Decision is the Latest Milestone for Diffusion Optics Technology™ (DOT™) Spectacle Lenses Designed to Slow Myopia Progression in Children LOS ALTOS, Calif., Feb. 14, 2024 /PRNewswire/ — SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments to address the global myopia epidemic, today announced that the U.S.… Continue reading SightGlass Vision Receives Breakthrough Device Designation from U.S. Food and Drug Administration
Summit Materials, Inc. Reports Fourth Quarter and Full Year 2023 Results
Establishes Annual Summit Records for Revenue and Profitability Record Annual Organic Pricing Growth for Aggregates and Cement DENVER, Feb. 14, 2024 /PRNewswire/ — Summit Materials, Inc. (NYSE: SUM) (“Summit,” “Summit Materials,” “Summit Inc.” or the “Company”), market-leading producer of aggregates and cement company, today announced results for the fourth quarter and full year ended December… Continue reading Summit Materials, Inc. Reports Fourth Quarter and Full Year 2023 Results
Jazz Pharmaceuticals to Report 2023 Full Year and Fourth Quarter Financial Results on February 28, 2024
DUBLIN, Feb. 14, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 full year and fourth quarter financial results on Wednesday, February 28, 2024, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. ET / 9:30 p.m. GMT… Continue reading Jazz Pharmaceuticals to Report 2023 Full Year and Fourth Quarter Financial Results on February 28, 2024
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors
WASHINGTON, Feb. 14, 2024 /PRNewswire/ — Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today appointed Russell Glass to its Board of Directors. Glass has almost 25 years of experience as a successful technology… Continue reading Evolent Adds Russell Glass, Headspace CEO, to Board of Directors
Equinix Declares Quarterly Dividend on Its Common Stock
REDWOOD CITY, Calif., Feb. 14, 2024 /PRNewswire/ — Equinix, Inc. (Nasdaq: EQIX), the world’s digital infrastructure company®, today announced that its Board of Directors has declared a quarterly cash dividend of $4.26 per share on its common stock. The quarterly common stock dividend will be paid on March 20, 2024, to shareholders of record on February… Continue reading Equinix Declares Quarterly Dividend on Its Common Stock
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
SAN DIEGO, Feb. 14, 2024 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal second quarter ended December 31, 2023, and provided a corporate update. RECENT CORPORATE DEVELOPMENTS Announced the initiation of an open… Continue reading Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update